The bad omens for the global economy seem to be piling up to form a gloomy picture. Professor Richard Wolff is on hand to sift through what troubles may be on the horizon. Plus, the ruling against Johnson & Johnson may be a major breakthrough in the opioid crisis, and a disaster for the company, but their stock is doing fine. Danielle Shay of Simpler Trading joins us to break down the latest moves for opioid-exposed drug companies, and the rest of the pharma sector.
